Fang et al. reported a case of a patient with refractory epithelial ovarian cancer, who had a partial response and 17-month survival after receiving two infusions of autologous CAR-T cells with scFv specific for MSLN and PD-1 (alpha PD-1-mesoCAR-T cells). Here, MSLN is linked to ovarian carcinoma.